SCHEMBL22573804

SCHEMBL22573804

Cc1ccnc(NC(=O)c2cnc(-c3ccccc3)nc2N)c1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.58
▸ RAB9A P51151 9/20 0.57
▸ NPC1 O15118 8/20 0.57
▸ KMT2A Q03164 5/20 0.57
▸ POLB P06746 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ TP53 P04637 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ SORT1 Q99523 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ NFKB1 P19838 1/20 0.52
▸ NFKB2 Q00653 1/20 0.52
▸ RELA Q04206 1/20 0.52
▸ PKM P14618 1/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MEN1 O00255 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573749 0.91 IDE (0.54) ATMRAB9ANPC1KMT2APOLB
SCHEMBL22573417 0.90 KMT2A (0.59) ATMRAB9ANPC1KMT2APOLB
SCHEMBL22573696 0.86 ATM (0.56) ATMRAB9ANPC1KMT2APOLB
SCHEMBL22573611 0.83 NPC1 (0.56) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL22573501 0.83 ADORA3 (0.60) ATMRAB9ANPC1KMT2APOLB
SCHEMBL22573633 0.82 MEN1 (0.58) RAB9ANPC1KMT2APOLBALDH1A1
SCHEMBL22573723 0.81 RAB9A (0.59) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2
SCHEMBL22573570 0.81 GRM5 (0.61) ATMRAB9ANPC1KMT2AALDH1A1
SCHEMBL22573719 0.81 LMNA (0.62) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2
SCHEMBL22573831 0.80 ATR (0.64) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback